Holen Sie sich die Stockscreener-App
5.22
0.67%
-0.02
Handel nachbörslich:
5.21
-0.010
-0.19%
Schlusskurs vom Vortag:
$5.24
Offen:
$5.22
24-Stunden-Volumen:
3.00M
Relative Volume:
0.78
Marktkapitalisierung:
$812.05M
Einnahmen:
$418.84M
Nettoeinkommen (Verlust:
$-1.60M
KGV:
-506.80
EPS:
-0.0103
Netto-Cashflow:
$69.77M
1W Leistung:
+13.40%
1M Leistung:
-17.64%
6M Leistung:
-43.05%
1J Leistung:
-54.42%
1-Tages-Spanne:
$5.12
$5.265
1-Wochen-Bereich:
$4.47
$5.285
52-Wochen-Spanne:
$4.45
$13.88
Certara Inc Stock (CERT) Company Profile
Firmenname
Certara Inc
Sektor
Branche
Telefon
(415) 237-8272
Adresse
4 RADNOR CORPORATE CENTER, SUITE 350, RADNOR
Compare CERT vs VEEV, BTSG, TEM, HQY, HNGE
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CERT
Certara Inc
|
5.22 | 815.16M | 418.84M | -1.60M | 69.77M | -0.0103 |
VEEV
Veeva Systems Inc
|
158.56 | 26.14B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
60.32 | 11.34B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
46.64 | 8.29B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
87.33 | 7.39B | 1.31B | 215.20M | 408.32M | 2.4627 |
HNGE
Hinge Health Inc
|
52.98 | 4.28B | 646.34M | -512.40M | 202.76M | -6.6871 |
Certara Inc Stock (CERT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-06 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2026-02-27 | Herabstufung | Craig Hallum | Buy → Hold |
| 2026-01-06 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-11-21 | Eingeleitet | Rothschild & Co Redburn | Buy |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-09-29 | Eingeleitet | Craig Hallum | Buy |
| 2025-07-03 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2025-05-08 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-02-27 | Eingeleitet | TD Cowen | Buy |
| 2024-09-27 | Hochstufung | UBS | Neutral → Buy |
| 2024-04-10 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-04-04 | Eingeleitet | JMP Securities | Mkt Perform |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2023-12-07 | Eingeleitet | UBS | Neutral |
| 2023-12-05 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2023-08-22 | Herabstufung | Jefferies | Buy → Hold |
| 2023-08-10 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-04-12 | Eingeleitet | Stephens | Overweight |
| 2023-04-03 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-12-14 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-09-08 | Eingeleitet | Berenberg | Buy |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-07-01 | Eingeleitet | Piper Sandler | Overweight |
| 2022-01-11 | Hochstufung | Jefferies | Hold → Buy |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Neutral |
| 2021-07-23 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2021-01-06 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-01-05 | Eingeleitet | BofA Securities | Buy |
| 2021-01-05 | Eingeleitet | Credit Suisse | Neutral |
| 2021-01-05 | Eingeleitet | Jefferies | Hold |
| 2021-01-05 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Certara Inc Aktie (CERT) Neueste Nachrichten
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Certara, Inc. (CERT) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Certara (CERT) shares slide after weak full-year guidance overshadows revenue beat - MSN
Bronstein, Gewirtz & Grossman, LLC Encourages Certara, Inc. (CERT) Investors to Inquire about Securities Investigation - ACCESS Newswire
CERT Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
CERT Investors Have Opportunity to Join Certara, Inc. Fraud Investigation with the Schall Law Firm - Caledonian Record
CERT Investors Have Opportunity to Join Certara, Inc. Fraud Investigation with the Schall Law Firm - GlobeNewswire Inc.
EDGAR Filing Documents for 0001827090-23-000010 - SEC.gov
Certara says AI investments will drive long-term growth – but traders are focused on one warning - MSN
Certara, Inc. (CERT) Q1 earnings miss estimates - MSN
Certara shares drop 19% after Q1 revenue decline and management inconsistency concerns. - Pluang
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation int - The National Law Review
CERT SHAREHOLDER ALERT: Investors Encouraged to Contact - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Certara, Inc.CERT - PR Newswire
CERT SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations - Business Wire
Certara’s SWOT analysis: life sciences stock faces leadership shift By Investing.com - Investing.com Australia
Certara’s SWOT analysis: life sciences stock faces leadership shift - Investing.com
Certara to Participate in Upcoming Investor Conferences - The Manila Times
Certara schedules RBC, William Blair and Jefferies investor appearances - Stock Titan
Certara expects $395M-$405M 2026 revenue following medical writing divestiture - MSN
Certara's US$101m Market Cap Fall Books Insider Losses - 富途牛牛
Certara stock (US1567671046): AGM voting results and fresh insider RSU awards draw investor attentio - AD HOC NEWS
Certara Shareholders Back Directors, Auditor and Executive Pay - TipRanks
Certara (CERT) reveals 2026 annual meeting director and proposal votes - Stock Titan
Certara | 4: Statement of changes in beneficial ownership of securities-Director CASHMAN JAMES E III - Moomoo
Certara (CERT) director converts 15,757 RSUs into common stock - Stock Titan
Certara | 4: Statement of changes in beneficial ownership of securities-Director Crane Rosemary A - Moomoo
Certara (CERT) CFO Reynders gains shares as RSUs vest and new 33,222-unit grant awarded - Stock Titan
Certara (CERT) chairman adds 15,757 shares and 33,222 RSUs in equity awards - Stock Titan
Certara (CERT) director reports 5,547 shares from RSUs and 33,222 new RSUs - Stock Titan
Certara (CERT) chair exercises 15,757 RSUs and receives 33,222-unit grant - Stock Titan
Certara (NASDAQ: CERT) director adds shares through RSU vesting and new grant - Stock Titan
Certara (CERT) director Crane receives 15,757 shares from RSU vesting - Stock Titan
Certara (CERT) director adds 15,757 shares and receives 33,222 RSUs - Stock Titan
Law firm investigates Certara after Q1 revenue drop and 19% stock plunge - Pluang
CERTARA INVESTOR ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire
Certara stock (US1567671046): Q1 revenue up 1% but services decline sparks investigation - AD HOC NEWS
Earnings call transcript: Certara Q1 2026 results miss EPS forecast, stock drops - Investing.com
CERTARA, INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud - The AI Journal
Certara (CERT) grants PSUs and RSUs to executive Robert Aspbury - Stock Titan
Certara (CERT) grants new PSUs and RSUs to President and Chief Commercial Officer - Stock Titan
Finanzdaten der Certara Inc-Aktie (CERT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Certara Inc-Aktie (CERT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Reynders John V W | Chief Financial Officer |
May 14 '26 |
Option Exercise |
0.00 |
15,757 |
0 |
26,466 |
| BROSHY ERAN | Chairman |
May 14 '26 |
Option Exercise |
0.00 |
15,757 |
0 |
50,708 |
| Bedi Arjun | Director |
May 14 '26 |
Option Exercise |
0.00 |
5,547 |
0 |
5,547 |
| CASHMAN JAMES E III | Chairman |
May 14 '26 |
Option Exercise |
0.00 |
15,757 |
0 |
484,197 |
| Killefer Nancy | Director |
May 14 '26 |
Option Exercise |
0.00 |
15,757 |
0 |
51,846 |
| Crane Rosemary A | Director |
May 14 '26 |
Option Exercise |
0.00 |
15,757 |
0 |
45,672 |
| WALSH MATTHEW M | Director |
May 14 '26 |
Option Exercise |
0.00 |
15,757 |
0 |
213,316 |
| Resnick Jon Matthew | Chief Executive Officer |
May 11 '26 |
Option Exercise |
0.00 |
59,766 |
0 |
59,766 |
| Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL OFF |
Apr 01 '26 |
Option Exercise |
0.00 |
33,167 |
0 |
113,744 |
| McKemey Adrian | President, Drug Dev. Solutions |
Apr 01 '26 |
Option Exercise |
0.00 |
10,849 |
0 |
10,849 |
2.63%
3.95%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):